CoChat

Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus

Open access
Tschöpe, Diethelm, Bramlage, Peter, Schneider, Steffen, Gitt, Anselm K · 2016 · Diabetes and Vascular Disease Research

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

Abstract

Aims: With the intensification of antidiabetic treatment, there is an increasing risk of hypoglycaemia. We aimed to determine incidence, characteristics and outcomes. Methods: Prospective, observational, multicenter cohort study. The included 3810 patients with type 2 diabetes had their treatment intensified at baseline. Results: The incidence of hypoglycaemia was 11.4% per year with 4.2 ± 4.4 episodes per patient. Hypoglycaemia was more frequent in patients with high blood glucose variability. Predictors were heart failure (odds ratio: 1.66; 95% confidence interval: 1.20–2.29) and insulin use (odds ratio: 4.03; 95% confidence interval: 3.05–5.33), with dipeptidyl peptidase–4 inhibitors being associated with reduced risk (odds ratio: 0.69; 95% confidence interval: 0.53–0.89). Macrovascular events were more frequent among patients reporting severe episodes of hypoglycaemia (odds ratio: 3.39; 95% confidence interval: 1.32–8.73). Microvascular events were more frequent in patients with non-severe episodes (odds ratio: 1.92; 95% confidence interval: 1.49–2.49). Conclusion: Case-by-case evaluation of patients as well as appropriate selection of antidiabetic pharmacotherapy and blood glucose treatment goals could maximize the benefits while reducing the risks of antidiabetic treatment.

Overview

Integrity signals

Registry

Crossref · 10.1177/1479164115610470

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Research works printed but not linked: 1

  1. Cox DJ, 1994, J Clin Endocrinol Metab, 79, 1659

Cited by

See all 12

Metadata

Authors
Tschöpe, D., Bramlage, P., Schneider, S., & Gitt, A. K.
Affiliations
  • Heart and Diabetes Center North Rhine-Westphalia (DE)
  • IPPMed (Germany) (DE)
  • Stiftung Institut für Herzinfarktforschung (DE)
Corresponding author
Tschöpe, Diethelm
Venue
Diabetes and Vascular Disease Research
Published
2015-11-12
Volume
13
Issue
1
Pages
2-12
ISSN
  • 1479-1641 (ISSN-L)
  • 1752-8984
OpenAlex
W2280487143
Cited by
12
References
44
Citations by year
2026: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 1
FWCI
1.73
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Diabetes and Vascular Disease Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Bristol-Myers Squibb
  • AstraZeneca
  • Diabetes-Stiftung
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
hypoglycemia, type 2 diabetes, hypoglycaemia incidence, glycemic variability, heart failure, insulin therapy, DPP-4 inhibitors, macrovascular events, antidiabetic pharmacotherapy
MeSH terms
Aged, Amputation, Surgical, Blood Glucose, Depressive Disorder, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Diabetic Retinopathy, Female, Heart Failure, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Metformin, Middle Aged, Patient Care Planning, Prospective Studies, Risk Factors, Sulfonylurea Compounds, Incidence, Odds Ratio, Thiazolidinediones, Dipeptidyl-Peptidase IV Inhibitors, Asymptomatic Diseases, Angina, Stable, Glycoside Hydrolase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus. https://app.cochat.ai/papers/10.1177/1479164115610470
The paper
Tschöpe, D., Bramlage, P., Schneider, S., & Gitt, A. K. (2016). Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus. Diabetes and Vascular Disease Research. https://doi.org/10.1177/1479164115610470

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.